Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Uncategorized
What You Don’t Know About AMP Can Hurt You: PART 1 – In the Beginning
Since the US Government uses AMP to set Medicaid rebates, as well as the Medicaid Federal Upper Limit (FUL), it is vital the…
Give Thanks for Your Compliance Officers – Reviewing Public Citizen’s Study…
Thanks to an increase in experienced compliance officers, settlements and court judgments between pharmaceutical manufacturers and…
It’s A Brave New World or Is It? – CIAs and Their Ability to Create…
Corporate Integrity Agreement (CIAs) are a tool commonly employed by the HHS OIG to resolve healthcare fraud issues. This article…
Pfizer: Another Settlement Down
The agreement in principle reached between Pfizer, Inc. and the Department of Justice has been finalized. The deal includes $784.6…
Dentsply v. Bates: Taking a “Bite” Out of False Claim Act (FCA) Violations…
Recently the U.S. District Court for the Eastern District of Pennsylvania dismissed Plaintiffs’ qui tam False Claim Act (FCA)…
Medical Affairs Strategic Summit West 2016
This year’s Medical Affairs Strategic Summit (MASS) West will be held September 14 – 2016, 2016 at the Hard Rock Hotel San Diego.…
Valeant Finally Able to Close One Troubled Door with Salix Settlement
Salix, a subsidiary of Valeant Pharmaceuticals International, Inc., recently settled claims involving Anti-Kickback and False…
Annual Forum on Transparency and Aggregate Spend
The Tenth Annual Forum on Transparency and Aggregate Spend will be held August 15 – 17, 2016, at the Ritz-Carlton in…
Valeant Finally Able to Close One Troubled Door with Salix Settlement
Salix, a subsidiary of Valeant Pharmaceuticals International, Inc., recently settled claims involving Anti-Kickback and…
US Senate Committee on Homeland Security, Hearing: America’s Insatiable…
Prescription drugs have been in the news for months: pricing issues, transparency problems, and the presidential…